IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,561 | +82.8% | 162,462 | +200.7% | 0.00% | 0.0% |
| Q2 2023 | $150,206 | +55.6% | 54,031 | +1.9% | 0.00% | – |
| Q1 2023 | $96,516 | -64.1% | 53,031 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $268,867 | +1.1% | 53,031 | -0.9% | 0.00% | 0.0% |
| Q3 2022 | $266,000 | +33.7% | 53,531 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $199,000 | +7.6% | 53,531 | +62.2% | 0.00% | 0.0% |
| Q1 2022 | $185,000 | -8.0% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $201,000 | -37.4% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $321,000 | -10.1% | 33,000 | +32.0% | 0.00% | 0.0% |
| Q2 2021 | $357,000 | -11.6% | 25,000 | +47.1% | 0.00% | -50.0% |
| Q1 2021 | $404,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $4,180,000 | 0.56% |
| HARBOURVEST PARTNERS LLC | 335,709 | $2,041,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $586,000 | 0.20% |
| SHEETS SMITH WEALTH MANAGEMENT | 152,276 | $926,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 129,260 | $786,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 140,551 | $855,000 | 0.09% |
| Virtus ETF Advisers LLC | 28,969 | $176,000 | 0.07% |
| XTX Topco Ltd | 19,159 | $116,000 | 0.07% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 49,464 | $301,000 | 0.04% |
| Vident Investment Advisory, LLC | 168,476 | $1,024,000 | 0.03% |